OFIXOrthofix Medical Inc.

$503M

Q2 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$199M+6.2% YoY

Gross Profit

$135M67.8% margin

Operating Income

-$25M-12.5% margin

Net Income

-$33M-16.8% margin

EPS (Diluted)

$-0.88

QoQ Revenue Growth

+5.3%

Cash Flow

Operating Cash Flow

$9M

Free Cash Flow

-$732,000

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$882M

Total Liabilities

$336M

Stockholders' Equity

$546M

Cash & Equivalents

$26M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$199M	$187M	+6.2%
Gross Profit	$135M	$120M	+12.7%
Operating Income	-$25M	-$37M	+32.0%
Net Income	-$33M	-$39M	+15.2%

Revenue Segments

Global Spine

$168M85%

Global Orthopedics

$31M15%

Geographic Segments

Other Countries

$16M56%

ITALY

$5M18%

FRANCE

$4M12%

GERMANY

$2M8%

BRAZIL

$2M6%

OFIX Q2 2024 Earnings — Orthofix Medical Inc. Revenue & Financial Results | Market Cap Arena